CIK 0000899923 · Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870494517
- Phone
- 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-14 | Muzzey Dale Chief Scientific Officer | Shares withheld for taxes | −8,288 | $4.66 | $39K | 346,007 |
| 2026-03-14 | Haas Kevin Richard Chief Technology Officer | Shares withheld for taxes | −4,161 | $4.66 | $19K | 191,759 |
| 2026-03-14 | Raha Samraat S. President and CEO | Shares withheld for taxes | −10,816 | $4.66 | $50K | 1,064,541 |
| 2026-03-14 | Verratti Mark Chief Operating Officer | Shares withheld for taxes | −5,418 | $4.66 | $25K | 647,477 |
| 2026-03-14 | Solaiman Shereen Chief People Officer | Shares withheld for taxes | −5,784 | $4.66 | $27K | 267,801 |
| 2026-03-13 | Wheeler Benjamin Richard Chief Financial Officer | Shares withheld for taxes | −586 | $4.66 | $3K | 303,224 |
| 2026-03-13 | Muzzey Dale Chief Scientific Officer | Shares withheld for taxes | −12,779 | $4.66 | $60K | 354,295 |
| 2026-03-13 | Fox Jennifer Lynne Chief Legal Officer | Shares withheld for taxes | −5,995 | $4.66 | $28K | 310,362 |
| 2026-03-13 | Haas Kevin Richard Chief Technology Officer | Shares withheld for taxes | −6,412 | $4.66 | $30K | 195,920 |
| 2026-03-13 | Raha Samraat S. President and CEO | Shares withheld for taxes | −36,304 | $4.66 | $169K | 1,075,357 |
| 2026-03-13 | Verratti Mark Chief Operating Officer | Shares withheld for taxes | −9,164 | $4.66 | $43K | 652,895 |
| 2026-03-13 | Solaiman Shereen Chief People Officer | Shares withheld for taxes | −8,899 | $4.66 | $41K | 273,585 |
| 2026-03-12 | Wheeler Benjamin Richard Chief Financial Officer | Grant or award | +206,186 | 303,810 | ||
| 2026-03-12 | Donnelly Brian J Chief Commerical Officer | Grant or award | +226,804 | 624,338 | ||
| 2026-03-12 | Muzzey Dale Chief Scientific Officer | Grant or award | +173,196 | 367,074 | ||
| 2026-03-12 | Fox Jennifer Lynne Chief Legal Officer | Grant or award | +195,876 | 316,357 | ||
| 2026-03-12 | Raha Samraat S. President and CEO | Grant or award | +618,557 | 1,111,661 | ||
| 2026-03-12 | Verratti Mark Chief Operating Officer | Grant or award | +247,423 | 662,059 | ||
| 2026-03-12 | Solaiman Shereen Chief People Officer | Grant or award | +173,196 | 282,484 | ||
| 2026-03-09 | Raha Samraat S. President and CEO | Purchase | +40,000 | $5.00 | $200K | 493,104 |
Page 3 of 15 · 286 trades